# Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis

> **NCT02339441** · — · COMPLETED · sponsor: **University of Manchester** · enrollment: 320 (actual)

## Conditions studied

- Early Diffuse Cutaneous Systemic Sclerosis

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT02339441
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2015-12
- **Final completion:** 2016-03
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2016-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02339441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02339441, "Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02339441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*